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Abstract: Selective cyclooxygenase inhibitors have attracted much attention in recent times
in the design of new non-steroidal anti-inflammatory drugs (NSAID). 3D-QSAR studies
have been performed on a series of 1,5-diarylpyrazoles that act as selective cyclooxygenase-
2 (COX-2) inhibitors, using three different methods: comparative molecular field analysis
(CoMFA) with partial least squares (PLS) fit; molecular field analysis (MFA) and; receptor
surface analysis (RSA) with genetic function algorithms (GFA). The analyses were carried
out on 30 analogues of which 25 were used in the training set and the rest considered for the
test set. These studies produced reasonably good predictive models with high cross-validated
and conventional r2 values in all the three cases.
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Introduction
Cyclooxygenase (COX) converts arachidonic acid to prostaglandin (PG)H2 and subsequently to a
number of other prostaglandins which are potent mediators of inflammation. COX exists in two differ-
ent isoforms, namely, COX-1 and COX-2 [1] COX-1 is constitutively expressed in tissues and is re-
sponsible for the physiological production of prostaglandins. However, COX-2, the induced isoform, is
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responsible for the elevated production of prostaglandins during inflammation [2]. Thus the selective
inhibition of COX-2 is very important in the design of NSAID molecules. Inhibition of COX-1 pro-
duces undesirable gastrointestinal side effects and therefore selectivity is a highly desirable attribute in
a potential NSAID [3]. Thus our main objective is to design specific inhibitors of COX-2 in the hope
that these molecules may be further explored as powerful non-ulcerogenic anti-inflammatory agents.
Though both structure- and analogue-based drug design methods have been used in NSAID design in
the past, only the latter type of studies have been carried out in the present study.
Computational Methods
Molecular 3D Structure Building
With the satisfactory understanding of the model of the drug action of many NSAIDs, there has
been an increased impetus in the synthesis of many COX-2 specific diarylcyclopentane and related het-
erocyclic systems. From one such report wherein a number of diarylpyrazoles were synthesized and the
biological activity evaluated for both COX-1 and COX-2, 30 molecules were randomly selected for the
present study (Scheme 1, Tables 1 and 2) [4]. All inhibitors were modelled with Sybyl. Initial geomet-
ric optimizations were carried out using the standard Tripos force field, with a 0.001 Kcal/mol energy
gradient convergence criterion and a distance-dependent dielectric constant employing Gasteiger
charges [5]. Further geometric optimizations were performed using MOPAC with the AM1 Hamilto-
nian and derived MOPAC charges were used for the subsequent analysis [6,7]. The final geometry of
the molecular skeleton is very similar to that of SC-558 and Celecoxib [2,8].
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Scheme 1.
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Alignment
Fragment 1 is common to all the molecules that were considered in this study and the molecules
were aligned with respect to this fragment, using the simple alignment method in Sybyl (Figure 1).
Alignment by different methods such as field fit or pharmacophore fit were also carried out. However,
these studies did not produce any significant deviation in the results obtained from the earlier studies.
           Fragment 1                                
Figure 1. Fragment 1 and alignment of all molecules using the Sybyl database alignment procedure.
CoMFA
CoMFA fields were generated using the standard Tripos field and 3D-QSAR analysis was per-
formed by the PLS method [9]. For each cross-validated CoMFA analysis, the minimum σ value was
set to 2 to expedite calculations. For the non cross-validated CoMFA analyses, the minimum σ value
was set to 0. The steric and electrostatic field energies were calculated using an sp3 carbon probe atom
with a +1 charge. The CoMFA grid spacing was 2.0 Å in all three dimensions within the defined re-
gion, and this was extended beyond the van der Waals envelopes of all molecules by at least 4.0 Å. The
optimal number of components in the final PLS model was determined by minimizing the standard er-
ror between the predicted and actual activities, obtained from the leave-one-out cross-validation tech-
nique. It is essential to assess the predictive power of the CoMFA model by using a test set of com-
pounds. Therefore, among the 30-inhibitors initially considered, 25 were randomly selected to be in-
cluded in the training set and the remaining five were used in the test set. The molecular systems were
rotated in the initially defined field box to test for orientation effects. However, no such effect was ob-
served. Similarly, q2-GRS studies employing a grid spacing of 1.0 Å and a cut-off of 0.1 and 0.2 q2 did
not improve the r2cv to any significant extent. Figures 2a and b represent the CoMFA contour maps of
steric and electrostatic contributions.
N
N
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Figure 2. Stereoviews of steric (a) and electrostatic (b) CoMFA contour plots for pyrazole 1. (a) Bulky
substituents enhance activity in the regions shaded green and depress activity in the yellow regions. (b)
Electropositive substituents enhance activity in the regions shaded blue and depress activity in the red
regions.
MFA
MOPAC minimized structures were also read into Cerius2 and all the molecules were aligned with
respect to Fragment 1 (Figure 3) [10]. The molecular field was created using as probes, the methyl
group and a proton for steric and electrostatic interactions respectively. Many of the spatial and struc-
tural descriptors such as polarizability, dipole moment, radius of gyration, molecular area, molecular
dimensions, density, principal moments of inertia, molecular volume, molecular weight, number of
rotatable bonds, hydrogen bond donors and acceptors, log P, molar refractivity and others were also
considered along with field values [11]. Only 10% of the total variables whose variance is highest were
considered as independent variables. The negative logarithm of the biological activity was chosen as
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the dependent variable in the generation of QSAR equations using the GFA regression method (with
only linear terms involved in the equations) [12]. All 25 molecules in the training set were considered
as observations. The other specifications are similar to those given in the following section.
Figure 3. Molecular alignment (Cerius2) based on Fragment 1. Note the very similar molecular super-
positions in both Figures 1 and 3. Still, some subtle differences may be observed.
RSA
Previous Cerius2 aligned molecules were reconsidered for the generation of a receptor surface [13].
The receptor surface was generated with weights based on the biological activity data. The interaction
energies of all the molecules were evaluated within this receptor model. The receptor surface descrip-
tors, expressed as field values based on the probes of methyl group and a proton, were added to the
study table along with various types of interaction energies for the QSAR study. Regression analysis
was carried out using the GFA method consisting of over 20,000 generations and with specific inclu-
sion of constant, linear, spline, quadratic, offset quadratic and quadratic spline variable terms in a
QSAR equation with no fixed length and with no scaling.
Results and Discussion
CoMFA
The CoMFA model with 25 compounds produced an r2cv value of 0.659 (maximum value of r2cv
was obtained with a minimum of 6 components) and a conventional correlation coefficient (r2) of
0.988 with the standard error of estimate being 0.149. The relative contributions of the steric and elec-
trostatic fields are 0.625 and 0.375 respectively. The real validity of the model is expressed in terms of
its ability in the prediction of biological activity for new molecules, in other words to predict the activ-
ity of those compounds not included in the building of the model. A close analysis of different validity
tests indicates that the model generated by the CoMFA analysis is very good. While the actual and pre-
dicted activities for the training set are given in Table 1, Table 2 contains the same data for the test set
molecules. Table 3 contains additional information regarding model quality.
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Table 1. Structures, and experimental and calculated inhibitory activities, -(log IC50), of the molecules
used in the training set based on the molecular skeleton defined in Scheme 1.
Calculated activity
Comp. No. R1, R2 R3
Activity
-(logIC50) CoMFA MFA RSA
1 3-CH3-4-SCH3 CF3 2.43 2.23 2.40 2.10
2 3-Cl-4-NHCH3 CF3 1.57 1.60 1.15 0.53
3 3-Cl-4-OCH3-5-CH3 CF3 1.18 1.04 1.14 0.97
4 2,4-di-Cl CF3 1.25 1.15 1.25 0.64
5 2,4-di-CH3 CF3 0.92 1.07 0.93 0.72
6 2-F CF3 1.24 1.22 1.19 1.51
7 4-F CF3 1.39 1.15 1.65 1.58
8 2-Cl CF3 1.25 1.34 1.25 0.64
9 2-Me CF3 1.16 1.20 1.01 1.42
10 3-Me CF3 0.96 1.14 1.08 1.41
11 4-CF3 CF3 -0.92 -0.85 -1.12 -0.47
12 2-OMe CF3 0.54 0.67 -0.60 0.32
13 4-OEt CF3 0.19 0.27 0.55 -0.42
14 4-SMe CF3 2.05 2.22 2.02 2.02
15 2-NMe2 CF3 -1.16 -1.34 -0.67 -1.04
16 4-NHMe CF3 1.80 1.90 0.82 1.52
17 4-CO2H CF3 -1.05 -1.05 -1.13 -0.87
18 3-C2H5-4-OCH3 CF3 0.37 0.40 -0.07 0.96
19 3,4-di-OCH3 CF3 0.22 0.27 1.65 -0.02
20 4-SO2Me CF3 -2.00 -2.08 -1.68 -1.18
21 4-CO2H CHF2 -1.67 -1.48 -1.59 -1.60
22 4-OMe CHF2 1.82 1.83 1.48 1.76
23 3-Cl-4-OCH3 CHF2 1.57 1.44 1.31 1.55
24 3,5-di-Cl-4-OCH3 CHF2 1.68 1.61 1.43 2.29
25 3,5-di-F-4-OCH3 CHF2 0.46 0.39 0.31 0.08
Table 2. Structures, and experimental and predicted inhibitory activities, -(log IC50), of the molecules
used in the test set.
Predicted Activitya
Comp. No. R1, R2 R3
Activity
-(logIC50) CoMFA MFA RSA
26 4-Cl CF3 2.00 1.04 1.84 1.25
27 4-Me CF3 1.40 0.79 1.11 1.24
28 4-NO2 CF3 -0.42 -0.77 -1.72 0.33
29 4-NMe2 CF3 2.33 2.32 -0.70 0.89
30 3-F-4-OCH3 CHF2 1.30 1.40 1.54 1.32
arms values for the three models are 0.534, 1.486 and 0.803 respectively
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Table 3. Details of CoMFA, MSA, and RSA calculations.
CoMFA MFAc RSAd
r 2cv 0.66 0.73 0.77
ar 2 0.99 (0.62 and 0.37) 0.86 0.90
No. of components 6 4 4
PRESSb 0.4 9.7 7.756
Standard deviation 0.13 0.43 0.4
aConventional r2 and the steric and electrostatic contributions are given in the parenthesis.
bPRESS = predicted sum of squares is the root mean square error of all target predictions.
cQSAR equation: Activity = 0.947055 - 0.258821(Ele/401) + 0.085612(vdW/392) +
0.122799(Ele/391) - 0.7848(vdW/350).
dQSAR equation: Activity = 0.546816 - 624.921(vdW/1726)2 + 31.65(vdW/505)2 +
602.116(vdW/1563)2 - 50.1242(-0.1561-vdW/517)2 -0.11822(Ele/1673).
CoMFA coefficient contour maps
The results of QSAR analysis by CoMFA, with its thousands of terms, was generally represented in
the form of three-dimensional “coefficient contour” maps. The CoMFA steric and electrostatic fields
are represented as coloured contour regions in Figures 2a and 2b respectively. For reference, molecule
1 is displayed in both maps. The green polyhedra in Figure 2a indicate the regions where more bulky
substituents are expected to increase the activity; in Figure 2b, any electropositive substituents in the
blue regions or electronegative substituents in the red regions enhance the activity. With substituents in
appropriate positions, more than one effect may be anticipated (Table 2).
Figures 2a and 2b show the absence of any CoMFA contouring in the ring A region. This is not sur-
prising because all the molecules in the training set are identical in this region. In the absence of any
data pertaining to the effect of substitution on ring A, one is unable to say whether or not substitution
on this ring will lead to activity variations. However, when the substitution on ring B is varied, there is
a significant variation in activity. The electrostatic contour (Figure 2b) shows a favourable interaction
of a more electronegative substituent at the 3-position of the ring and this could be due to the presence
of both CF3 and CHF2 groups among the training set molecules, with the former generally being the
more active.
MFA
The QSAR model with 25 compounds yielded a r2cv of 0.730 and a conventional correlation coeffi-
cient (r2) of 0.860. The predictive ability of this MFA model was evaluated by predicting the biological
activities of the test set molecules. The predicted and actual activities of the training set and test set
molecules are given in Table 1 and 2 while Table 3 features some of the data relating to the validation
tests. Figure 4 is the stereoview of the molecules in the training set with a rectangular field grid. Only
those field points involved in the QSAR equation are shown in the figure. It is noteworthy that a soli-
tary grid point near ring A is included along with the several grid points near ring B in the QSAR
equation.
Molecules 2000, 5 952
Figure 4. Stereoview of the molecular rectangular field grid around the superposed molecular units.
Both steric (CH3) and electrostatic (H+) grid points in the final QSAR equation are labelled.
RSA
The QSAR model generated using the RSA produced a r2cv of 0.77 and a conventional correlation
coefficient (r2) of 0.9. The predictive ability of this model was evaluated by predicting the biological
activities of the training set and test set molecules and the actual, predicted activities are given in Ta-
bles 2 and 3. Figure 5 is a stereoview of the receptor surface also showing the molecules in the training
set. The violet and green colours indicate favourable and unfavourable interactions respectively, be-
tween the molecules and the receptor surface. In Figure 5, while the pyrazole ring and ring A show
generally favourable interactions, ring B is not optimized. Thus, substitution patterns may be changed
such that the interactions are also optimized with concomitant increase in activity. Thus all the grid
points that are part of the QSAR equation are part of this region. The receptor model also supports the
models generated by the other two methods.
Figure 5. Stereoview of the receptor surface with all molecules considered and weights based on bio-
logical activities. Interaction energies of individual molecules on the receptor surface are coloured
(violet for a favourable interaction and green for an unfavourable one). The grid points involved in the
final QSAR equation are labelled which mainly originates from different substituted phenyl ring which
is neither violet nor green indicating substitution maneuvering is possible there without significant loss
of biological activity.
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It is of interest to compare the three models (Table 3, Figures 6a, 6b) with respect to the actual and
calculated activities and residuals for all the molecules in the training set.  Here, it appears that the
CoMFA model is slightly better than the other two (lesser number of off-diagonal points in Figure 6a
and bars of smaller height in Figure 6b). When only the test set is considered, the same trend continues
as seen from the order of rms values in Table 2. The CoMFA model performs better even when strong
electron withdrawing and electron donating groups (NO2, NMe2, F, OMe) are present.  MFA and RSA
models fare better when steric interactions involving Cl and Me substituents are considered. These
trends are reflected in part in the training set. It appears then that each method has advantages and dis-
advantages. Studies of the present type should not be confined to one model alone.
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Figure 6. (a) Plot of actual vs. calculated biological activities of the training set molecules in the three
methods of analysis. (b) Plot of residuals in the three methods of analysis. In general, CoMFA pro-
duced a better model.
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Conclusions
Three different analogue-based rational drug design methods have been used in the optimisation of
COX-2 selective inhibitor design. All three methods produce reasonably good models based on which
biological activities for the new molecules can be carried out.
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